Showing results (581-590 of 610) with videos related to
Sort By:
Pageof 61
Nature|November 3, 2020
Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York CityDaniel Stadlbauer, Jessica Tan, Kaijun Jiang, et al.Leukemia|November 12, 2016
Molecular alterations in bone marrow mesenchymal stromal cells derived from acute myeloid leukemia patientsE K von der Heide, M Neumann, S Vosberg, et al.Frontiers in Public Health|November 11, 2024
High SARS-CoV-2 secondary infection rates in households with children in Georgia, United States, Fall 2020-Winter 2021Kacy D Nowak, Morgan A Lane, Armand Mbanya, et al.BMJ Public Health|February 2, 2026
Roles of children, isolation measures and socioeconomic status in SARS-CoV-2 household transmission: a retrospective cohort study in a southern US cityJessica K Fairley, Serena S Leung, Brianna A Binion, et al.ESMO Open|November 26, 2025
Clinical benefit of additional whole-exome sequencing over panel sequencing in an all-comer real-world molecular tumor boardE Krieghoff-Henning, T Michaeli, T Boch, et al.The Journal of Molecular Diagnostics : JMD|May 7, 2022
RT-PCR/MALDI-TOF Diagnostic Target Performance Reflects Circulating SARS-CoV-2 Variant Diversity in New York CityMatthew M Hernandez, Radhika Banu, Ana S Gonzalez-Reiche, et al.Journal of Medical Virology|May 8, 2021
RT-PCR/MALDI-TOF mass spectrometry-based detection of SARS-CoV-2 in saliva specimensMatthew M Hernandez, Radhika Banu, Paras Shrestha, et al.Medrxiv : the Preprint Server for Health Sciences|June 6, 2022
A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variantsMatthew M Hernandez, Radhika Banu, Paras Shrestha, et al.Microbiology Spectrum|September 7, 2022
A Robust, Highly Multiplexed Mass Spectrometry Assay to Identify SARS-CoV-2 VariantsMatthew M Hernandez, Radhika Banu, Paras Shrestha, et al.Leukemia|June 18, 2026
Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker StudyS Rinaldetti, M Chepeleva, A Hedblom, et al.Pageof 61